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2504have favorable neurocognitive ef-
fects, but previous studies have
provided inconsistent results (5–8).
Several factors may contribute to
the inconsistency, including the
diversity of the patient population,
the difference in baseline cerebral
perfusion status, variability of
surgical and endovascular tech-
niques, the differences in neuro-
psychological testingmethodology,
and the possible learning effect on
repeated tests. Procedural emboli,
temporary ﬂow interruption, and
general anesthesia may also offset
the beneﬁt of improved cerebral
hemodynamics.
Our previous work has dem-
onstrated that successful CS can
improve global cognitive func-
tions as well as attention and psy-
chomotor processing speed inpage 2510patients with chronic internal carotid artery occlusion
(ICAO) (9), even in asymptomatic patients (10). The
results implied the reversibility of cognitive function in an
ischemic hemisphere after restoring cerebral perfusion.
Therefore, we conducted the present study with an
expanded patient cohort to assess the neurocognitive change
after CS in all patients with severe ICA disease, analyzed
according to baseline perfusion status of the ipsilateral
hemisphere and procedural result.
Methods
Patients. All patients were 18 years of age or older. From
July 2008 to January 2010, endovascular intervention was
attempted in 61 consecutive patients with severe ICA ste-
nosis or ICAO. The indication was diameter stenosis >60%
in symptomatic patients, and >80% in asymptomatic (2).
Patients with documented ICAO would be followed up
clinically for at least 2 months, and CS was only attempted
in patients with ischemic symptom progression or objective
hemisphere ischemia (11,12). We excluded patients with
ischemic stroke within 2 weeks, vascular disease precluding
catheter-based techniques, intracranial aneurysm or arterio-
venous malformation, history of bleeding disorder, any
surgery planned within 30 days, life expectancy <1 year,
educational level below elementary school, aphasia, right-
sided hemiparesis, marked depression, or at least moderate
dementia. Brain computed tomography (CT) perfusion
(CTP) with Diamox (acetazolamide) stress and a battery
of neuropsychological tests were performed before and
3 months after carotid intervention.NCF evaluation. Cognitive function evaluation was per-
formed by an independent clinical psychologist, who was
blinded to the outcomes of the intervention. Cognitive
assessment of global measures included the Mini-Mental
State Examination (MMSE) (13,14) and Alzheimer Dis-
ease Assessment Scale–Cognitive subscale (ADAS-Cog),
a widely used rating instrument assessing memory, orienta-
tion, language, and ideational and constructional praxis.
ADAS-Cog scores range from 0 to 70, with a higher score
indicating lower performance (15,16). Additional tests cov-
ering neuropsychological functions, such as executive func-
tion, working memory, and attention, are compatible with
the concept of VADAS-Cog and are suitable for our patients
with vascular-related cognitive impairment (17,18). Relevant
tasks included verbal ﬂuency (category naming: fruits, vege-
tables, and ﬁshes) and Color Trails Test Parts 1 and 2
(17,19). The Color Trails Test was used to replace the more
educational-dependent conventional Trail Making Test.
Interventional procedure and clinical follow-up. Aspirin
100 mg and clopidogrel 75 mg/day were started 7 days
before the procedure. CS procedure was done with tech-
niques described in the literature (2,20). The deﬁnition of
ICAO and the details of the interventional technique were
also described previously (11,12). Technical success was
deﬁned as implantation of stents after recanalization of the
lesion, with ﬁnal residual diameter stenosis 20% and
Thrombolysis In Myocardial Infarction ﬂow grade 3 ante-
grade. All patients were sent to the intensive care unit for
overnight hemodynamic and neurological monitoring, where
systolic blood pressure was carefully maintained within 100
to 140 mm Hg. Aspirin and clopidogrel were continued
for 3 months after successful intervention. Complete neu-
rological examinations, including assessment of National
Institutes of Health Stroke Scale (NIHSS) and Barthel
Index, were done by an independent neurologist before,
1 week, and 3 months after the procedure. Neurological se-
quelae, intracranial hemorrhage, and death were recorded.
Follow-up ultrasound examination was scheduled at 3
months after the intervention.
CT follow-up and analysis. CTP and CT angiography
by a multidetector CT scanner was scheduled before and
3 months after the procedure. Assessment of cerebral
perfusion (before and after the procedure) was performed by
2 independent investigators who were blinded to clinical and
angiographic outcomes. CT perfusion data were analyzed
separately off-line at a workstation using commercial soft-
ware (CT Perfusion 3, Advantage 4.2, GE Healthcare, Little
Chalfont, United Kingdom). Cerebral blood volume (CBV),
cerebral blood ﬂow (CBF), time to peak, and mean transit
time were calculated. The topographic pattern was catego-
rized into absence of asymmetry, watershed zones, and
vascular territory hypoperfusion. A grading system of quali-
tative assessment of brain perfusion in region of interest
was applied as the following: 0 ¼ complete perfusion;
1 ¼ hypoperfusion with preserved CBV (a lower CBF,
delayed time to peak, increased mean transit time, decreased
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2505ﬂow, and normal or elevated CBV); and 2 ¼ hypoperfusion
without adequate blood volume (i.e., decreased CBV).
Improvement of brain perfusion after the procedure was
deﬁned as at least 1 categorical number decrease in the region
of interest by the grading system.
Statistical analysis. Continuous data were presented as
median (interquartile ranges). Discrete data were given as
counts and percentages. Chi-square test or Fisher exact test
(if the group’s number is 5 or less) was used to compare
groups of categorical data. The Kruskal-Wallis equality-
of-populations rank test was applied to compare groups of
continuous unpaired data. Paired continuous data were
compared by the Wilcoxon signed rank test. Linear regres-
sion models were used to assess the correlation between the
change in brain perfusion and the changes in the results of 5
neuropsychological tests. A 2-sided p value of <0.05 was
considered statistically signiﬁcant. Stata/SE version 11.0 for
Windows (StataCorp LP, College Station, Texas) was used
for statistical analyses.Results
Patients. Sixty-one patients (44 men; age 68.9 
10.2 years, ranging 47 to 86 years), including 22 chronic
ICAO and 39 severe ICA stenoses, were included in the
analysis. Twenty-ﬁve patients (41%) had prior ipsilateral
ischemic events, with 14 having their last event within
6 months (NASCET symptomatic [North American
Symptomatic Carotid Endarterectomy Trial]). Six patients
(10%) had a history of neck radiotherapy for malignancy.
Twenty-one patients (34%) had contralateral ICA stenosis
>50%, with 12 of them undergoing CS according to theTable 1 Baseline Characteristics Among Groups
Group 1
(n ¼ 8)
Male 7 (88)
Age, yrs 60.5 (55–77.5)
Hypertension 7 (88)
Diabetes mellitus 2 (25)
Hyperlipidemia 6 (75)
Smoking 5 (63)
Coronary artery disease 5 (63)
Peripheral artery occlusive disease 1 (13)
Prior myocardial infarction 1 (13)
Chronic renal insufﬁciency 0 (0)
LVEF 67 (64–70)
Prior neck radiotherapy 1 (13)
Prior ipsilateral ischemic event 3 (38)
NASCET symptomatic at procedure 0 (0)
Target ICAO 8 (100)
Left ICA lesion 5 (63)
Contralateral ICA stenosis >50% 2 (25)
Procedure success 0 (0)
Values are n (%) or median (interquartile range).
ICA ¼ internal carotid artery; ICAO ¼ internal carotid artery occlusion; LVEF ¼ lef
Endarterectomy Trial.established indications before the index procedure. Ipsilat-
eral cerebral perfusion insufﬁciency was found in all 22
ICAO and 20 of 39 severe ICA stenosis patients by
baseline CTP. There was a signiﬁcant difference in baseline
cerebral perfusion scores between ICAO and severe ICA
stenosis groups (median and interquartile range: 2 [1 to 2]
vs. 0.5 [0 to 2], p < 0.001).
Procedure. Technical success was achieved in 14 of 22
ICAO (64%) and in all 39 severe ICA stenosis. The reason
of failure in ICAO patients was the inability to pass a
guidewire across the occlusion. One patient with left ICAO
had a small nonfatal ipsilateral intracranial hemorrhage
5 hours after successful recanalization and stenting, possibly
due to hyperperfusion. The neurological condition was
stabilized with medical treatment only, and the patient was
discharged 1 week later. One patient with left symptomatic
ICA stenosis had an embolic stroke during CS. After
neurosalvage with intra-arterial thrombolysis, the neurolog-
ical condition improved signiﬁcantly, and the patient was
discharged 10 days later with mild motor aphasia. These
2 patients were excluded from further NCF evaluation.
Grouping for analysis. Patients were divided into 3 groups
for analysis based on the pre-procedural CTP and interven-
tional results: group 1 (n ¼ 8) consisted of those with ipsi-
lateral abnormal cerebral perfusion and a failed CS procedure;
group 2 (n ¼ 33) consisted of those with abnormal ipsilateral
cerebral perfusion and successful CS; and group 3 (n ¼ 18)
consisted of those with symmetrical cerebral perfusion and
successful CS. Table 1 summarizes the baseline demo-
graphics and clinical characteristics in the different groups.
There were no signiﬁcant differences among groups, ex-
cept for the lower incidence of hyperlipidemia in group 3.Group 2
(n ¼ 33)
Group 3
(n ¼ 18) p Value
24 (73) 12 (67) 0.544
71 (65–78) 69 (60–75) 0.457
25 (75) 14 (78) 0.772
8 (24) 7 (39) 0.515
25 (76) 7 (39) 0.025
17 (52) 11 (61) 0.742
21 (64) 14 (78) 0.553
5 (45) 8 (44) 0.057
2 (6) 1 (6) 0.607
2 (6) 2 (11) 0.784
67 (62.5–73.5) 65 (60–72) 0.550
5 (14) 0 (0) 0.201
16 (48) 4 (22) 0.160
8 (24) 4 (22) 0.394
13 (39) 0 (0) <0.001
16 (48) 8 (44) 0.765
13 (39) 6 (33) 0.802
33 (100) 19 (100)
t ventricle ejection fraction; NASCET ¼ North American Symptomatic Carotid
Table 2 Baseline Neurological and Neurocognitive Function Among Groups
Group 1
(n ¼ 8)
Group 2
(n ¼ 33)
Group 3
(n ¼ 18) p Value
NIHSS 0 (0–1) 0 (0–0) 0 (0–0) 0.580
Barthel Index 100 (97.5–100) 100 (100–100) 100 (100–100) 0.608
ADAS 4.5 (3–6.5) 6 (4–9) 5 (4–8) 0.321
MMSE 28 (27–29) 27 (25–28) 28 (25–29) 0.189
Color Trails Test Part 1, s 70.5 (52.5–127.5) 100 (78.5–136.5) 74.5 (55–109) 0.195
Color Trails Test Part 2, s 115.5 (105.5–192) 180 (143–215.5) 151 (102–189) 0.181
Verbal ﬂuency 27.5 (24–37) 24 (20–30) 28 (25–32) 0.286
Values are median (interquartile ranges).
ADAS ¼ Alzheimer Disease Assessment Scale; MMSE ¼ Mini-Mental State Examination score; NIHSS ¼ National Institutes of Health Stroke Scale.
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2506The pre-procedural NIHSS, Barthel Index, and results of
5 neuropsychological tests were similar among the 3 groups
without statistical difference (Table 2).
Neurocognitive changes. Table 3 shows the changes of
the neurocognitive and neurological functions between
baseline and 3-month follow-up in the 3 groups. Signiﬁcant
improvement in ADAS-Cog (pre-procedure: 6 [4 to 9] vs.
post-procedure: 5 [3 to 7], p ¼ 0.002), MMSE (pre-
procedure: 27 [25 to 28] vs. post-procedure: 28 [25 to 29],
p ¼ 0.004), and Color Trails Test Part 1 (pre-procedure:
100 [78.5 to 136.5] s vs. post-procedure: 97 [60 to 128.5] s,
p ¼ 0.003) were observed in group 2. By comparison, there
was no signiﬁcant change in all test parameters at follow-
up in groups 1 and 3. NIHSS and Barthel Index were
stationary in 3 groups at 3-month follow-up compared with
baseline. Excluding ICAO patients in group 2, signiﬁcant
improvement in ADAS (pre-procedure: 6 [4.5 to 10.5] vs.
post-procedure: 5 [3.5 to 6.5], p ¼ 0.024) and MMSE (pre-
procedure: 26.5 [25.5 to 28] vs. post-procedure: 28 [25.5 to
29.5], p ¼ 0.016), and a trend of improved Color Trails Test
Part 1 (pre-procedure: 99 [77 to 124] vs. post-procedure: 97
[55 to 124], p ¼ 0.058), were still observed in the patients
with severe ICA stenosis (Table 4). Comparing the changes
of neurocognitive tests from baseline after stenting in
different groups, only Color Trails Test Part 1 was statis-
tically different among groups (group 1 vs. group 2 vs. group
3: 1.5 [14 to 11.5] vs. 12.5 [36.5 to 0.5] vs. 0.5 [11
to 27], p ¼ 0.0159), and the changes of ADAS and MMSE
were no longer different (ADAS, group 1 vs. group 2 vs.
group 3: 0.5 [1 to 1.5] vs. 2 [3 to 0] vs. 1 [2 to 0],
p ¼ 0.0887; MMSE, group 1 vs. group 2 vs. group 3: 0.5
[0 to 1.5] vs. 1 [0 to 2] vs. 0 [1 to 1], p ¼ 0.2751).
Correlation with perfusion. Ipsilateral brain perfusion
improvement at 3 months was documented in 28 of 33
(85%) patients in group 2, but none in groups 1 and 3.
Signiﬁcant correlation between the change in perfusion and
the change in MMSE (r ¼ 0.33, p ¼ 0.01) (Fig. 1A) was
noted. A possible correlation between the change in perfu-
sion and the change in Color Trails Test Part 1 results
(r ¼ 0.21, p ¼ 0.12) (Fig. 1B) was also noted. The corre-
lations between the change of perfusion and the changes of
ADAS (r ¼ 0.10), Color Trails Test Part 2 (r ¼ 0.11), or
verbal ﬂuency (r ¼ 0.05) were weak.Discussion
A decline in cognitive function caused by cerebral hypo-
perfusion has been termed “vascular cognitive impairment”
(21). The causative relationship between carotid artery
disease and cognitive impairment was ﬁrst proposed by
Fisher in 1951, based on a necropsy case (22). He also pos-
tulated that enhancement of cerebral perfusion by reopening
ICA stenosis may have a salutary effect on cognition.
Although the large, international randomized extracranial-
to-intracranial artery bypass trial, EC/IC Bypass Study
(International Cooperative Study of Extracranial/Intracranial
Arterial Anastomosis), failed to show the beneﬁt of stroke
prevention in patients with ICAO (23), several case series
of bypass surgery still revealed signiﬁcant improvement in
cognition, which may result from improved CBF (24,25).
By contrast, the temporary ﬂow arrest to the already
ischemic hemisphere by cross-clamping during the CE
procedure may offset the beneﬁt of improved ﬁnal cerebral
perfusion (26,27). Results of CE on cognition have been
controversial (6,7). However, several studies did demonstrate
that in patients with depressed CBF, uncomplicated CE
may improve cognitive function. Fearn et al. (28) found
improvement in attention after CE, especially in patients
with severely impaired baseline cerebrovascular reserve from
carotid stenosis. Kishikawa et al. (29) also showed an
improved mean score of the block design test after CE in
patients with impaired cerebral perfusion, but not in those
with preserved cerebral perfusion. These ﬁndings suggested
that cognition may improve in patients with ﬂow-limiting
carotid stenosis, because the impaired baseline CBF is
restored by carotid revascularization.
In the present study, we further demonstrated the beneﬁ-
cial effect of reperfusion on cognition. In patients with
baseline perfusion failure, we can detect signiﬁcant im-
provement on NCF after successful reperfusion. Comparing
the different outcomes of groups 2 and 3, and the correlation
between increased brain perfusion and improved cognitive
function, we conﬁrmed the role of cerebral hemodynamics
in cognitive outcome in CS patients. The “learning effect” in
patients re-evaluated after a short interval is a major concern,
and may have confounded the interpretation of results in
a number of prior studies showing cognitive improvement
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Table 4
Neurocognitive and Neurologic Function at Baseline
and 3 Months Post-Procedure in the Patients With
Severe ICA Stenosis and Objective Baseline Abnormal
Cerebral Perfusion (n ¼ 20)
Baseline
3 Months
Post-Procedure p Value
ADAS 6 (4.5–10.5) 5 (3.5–6.5) 0.024
MMSE 26.5 (25.5–28) 28 (25.5–29.5) 0.016
Color Trails Test Part 1, s 99 (77–124) 97 (55–124) 0.058
Color Trails Test Part 2, s 160 (129–199) 171 (124–207) 0.657
Verbal ﬂuency 25 (23–29.5) 27.5 (21.5–31.5) 0.910
NIHSS 0 (0–0) 0 (0–0) 1.000
Barthel Index 100 (100–100) 100 (100–100) 0.971
Values are median (interquartile range).
ICA ¼ internal carotid artery; other abbreviations as in Table 2.
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2507after carotid revascularization (6,7). The design of the
present study, however, mitigated this limitation completely.
Group 1 served as a perfect control, which not only had
similar baseline characteristics and perfusion status to group 2,
but also underwent a “sham” procedure. The results therefore
excluded the learning effect of tests done at short intervals.
CS is associated with shorter ipsilateral carotid ﬂow
interruption compared with CE (26), but it may carry
a higher risk of microembolization (26,30,31). Subclinical
microembolization during cardiac catheterization or surgery
is known to affect cognitive performance, despite the silent
neurological manifestation (32,33). Transient hypotension
occurs frequently in patients undergoing CS (34), and may
also worsen cerebral perfusion in patients with tandem or
diffuse intracranial arterial diseases. The net beneﬁt of
improved CBF on cognitive outcome after CS may thus be
offset and neutralized. Hence, it is understandable that
results of cognitive outcome after CS may be inconsistent (7).
We believe the design and results of the present study
demonstrate the beneﬁt on cognition of restoring perfusion
by CS. In fact, this beneﬁcial effect may be more potent
than our ﬁnding, because microembolization and systemic
hypotension are inherent to the procedure.
Different neurocognitive tests are designed to evaluate
different aspects of NCF. Although ADAS-Cog and
MMSE are nowadays the most commonly applied tools to
assess global cognitive function, they can only assess relatively
stable aspects of cognition and stratify the severity of cogni-
tive impairment in the population of mild-to-moderate
dementia. There might be a “ceiling effect” in patients with
minimal cognitive impairment, who constitute the majority
of the population with carotid stenosis. According to a
previous review of neurocognitive effects of CE (35), domains
containing psychomotor speed/reaction time, attention,
memory, and visuoconstructional organization (such as Color
Trails Test Part 1) may be more consistent and sensitive in
showing improvement after carotid revascularization. That is
probably why signiﬁcant changes from baseline could be
observed only in the Color Trails Test Part 1 in this cohort.
Study limitations. Despite the overall cognitive improve-
ment in group 2, there are still individual variations in the
Figure 1 Correlation of Brain Perfusion Changes to NCF Tests
(A) The correlation between the change in brain perfusion and the change in
Mini-Mental State Examination (MMSE) after the procedure. (B) The correlation
between the change in brain perfusion and the change of Color Trails Test Part 1.
The correlation coefﬁcient (r) and p value are shown. NCF¼ neurocognitive function.
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2508magnitude of changes in patients and tests. A larger number
of patients and more functional-speciﬁc or topographical
neuropsychological tests and imaging modalities will be
mandatory in the future. For example, magnetic resonance
imaging before and after a procedure may help to better
quantify prior infarct area and procedure-related micro-
embolism. Metabolic imaging such as 18F-ﬂuorodeoxy-
glucose positron emission scanning may help to correlate
anatomic reperfusion and recovery of speciﬁc cortical func-
tions after CS. The follow-up interval in the present study
was relatively short, and a longer observation period is
needed to demonstrate long-term improvement in cognitive
function. One intracranial hemorrhage and 1 embolic stroke
occurred in this small series, and the cognitive beneﬁts need
to be balanced by procedural risk in the future larger pop-
ulation, especially in asymptomatic patients.Conclusions
We concluded that successful CS can improve NCF in
patients with severe ICAO and objective abnormal cerebralperfusion. The improvement of cognition correlated well
with the improvement of ipsilateral brain perfusion.Reprint requests and correspondence: Dr. Hsien-Li Kao,
Department of Internal Medicine, National Taiwan University
Hospital, 7 Chung-Shan South Road, 100 Taipei, Taiwan. E-mail:
hsienli_kao@yahoo.com.
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